LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum.

    Lapierre, Thibault Joseph William Jacques Dit / Farago, Danilo Nascimento / de Moura Lodi Cruz, Mariza Gabriela Faleiro / de Melo Resende, Daniela / de Oliveira, Adriane Cristina Rosa / Dos Santos, Brenda Rosa Macedo / de Oliveira Souza, Felipe / Michelan-Duarte, Simone / Chelucci, Rafael C / Andricopulo, Adriano D / Ferreira, Leonardo L G / Pilau, Eduardo Jorge / Murta, Silvane Maria Fonseca / de Oliveira Rezende Júnior, Celso

    Chemical biology & drug design

    2024  Volume 103, Issue 4, Page(s) e14525

    Abstract: An early exploration of the benzothiazole class against two kinetoplastid parasites, Leishmania infantum and Trypanosoma cruzi, has been performed after the identification of a benzothiazole derivative as a suitable antileishmanial initial hit. The first ...

    Abstract An early exploration of the benzothiazole class against two kinetoplastid parasites, Leishmania infantum and Trypanosoma cruzi, has been performed after the identification of a benzothiazole derivative as a suitable antileishmanial initial hit. The first series of derivatives focused on the acyl fragment of its class, evaluating diverse linear and cyclic, alkyl and aromatic substituents, and identified two other potent compounds, the phenyl and cyclohexyl derivatives. Subsequently, new compounds were designed to assess the impact of the presence of diverse substituents on the benzothiazole ring or the replacement of the endocyclic sulfur by other heteroatoms. All compounds showed relatively low cytotoxicity, resulting in decent selectivity indexes for the most active compounds. Ultimately, the in vitro ADME properties of these compounds were assessed, revealing a satisfying water solubility, gastrointestinal permeability, despite their low metabolic stability and high lipophilicity. Consequently, compounds 5 and 6 were identified as promising hits for further hit-to-lead exploration within this benzothiazole class against L. infantum, thus providing promising starting points for the development of antileishmanial candidates.
    MeSH term(s) Leishmania infantum ; Antiprotozoal Agents/pharmacology ; Trypanosoma cruzi ; Benzothiazoles/pharmacology
    Chemical Substances Antiprotozoal Agents ; Benzothiazoles
    Language English
    Publishing date 2024-04-16
    Publishing country England
    Document type Journal Article
    ZDB-ID 2216600-2
    ISSN 1747-0285 ; 1747-0277
    ISSN (online) 1747-0285
    ISSN 1747-0277
    DOI 10.1111/cbdd.14525
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets.

    Laureano de Souza, Mariana / Lapierre, Thibault Joseph William Jacques Dit / Vitor de Lima Marques, Gabriel / Ferraz, Witor Ribeiro / Penteado, André Berndt / Henrique Goulart Trossini, Gustavo / Murta, Silvane Maria Fonseca / de Oliveira, Renata Barbosa / de Oliveira Rezende, Celso / Ferreira, Rafaela Salgado

    Expert opinion on therapeutic targets

    2023  Volume 27, Issue 10, Page(s) 911–925

    Abstract: Introduction: Chagas disease (CD) imposes social and economic burdens, yet the available treatments have limited efficacy in the disease's chronic phase and cause serious adverse effects. To address this challenge, target-based approaches are a possible ...

    Abstract Introduction: Chagas disease (CD) imposes social and economic burdens, yet the available treatments have limited efficacy in the disease's chronic phase and cause serious adverse effects. To address this challenge, target-based approaches are a possible strategy to develop new, safe, and active treatments for both phases of the disease.
    Areas covered: This review delves into target-based approaches applied to CD drug discovery, emphasizing the studies from the last five years. We highlight the proteins cruzain (CZ), trypanothione reductase (TR), sterol 14 α-demethylase (CPY51), iron superoxide dismutase (Fe-SOD), proteasome, cytochrome
    Expert opinion: Target-based approaches toward developing potential CD therapeutics have yielded promising leads in recent years. We expect a significant advance in this field in the next decade, fueled by the new options for
    MeSH term(s) Humans ; Chagas Disease/drug therapy ; Trypanosoma cruzi/genetics ; Drug Discovery
    Language English
    Publishing date 2023-10-30
    Publishing country England
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2055208-7
    ISSN 1744-7631 ; 1472-8222
    ISSN (online) 1744-7631
    ISSN 1472-8222
    DOI 10.1080/14728222.2023.2264512
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top